These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 26495531)

  • 21. [Efficacy of cytoflavin in the treatment of vertebrobasilar insufficiency].
    Beĭn BN; Dravert NE
    Eksp Klin Farmakol; 2010 Apr; 73(4):8-10. PubMed ID: 20486551
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Using cytoflavin for correcting x-ray contrasting agent-induced nephropathy].
    Karpishchenko SN; Zheregelia SN; Glushkov SI
    Eksp Klin Farmakol; 2010 Oct; 73(10):40-2. PubMed ID: 21254514
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Cerebral dysfunction after coronary artery bypass graft surgery with cardiopulmonary bypass].
    Tsygan IV
    Voen Med Zh; 2013 Nov; 334(11):30-5. PubMed ID: 24611306
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Investigation of markers for myocardial remodeling during experimental hypobaric hypoxia in the correction with cytoflavin].
    Sataeva TP; Zadnipryany IV
    Arkh Patol; 2018; 80(6):35-42. PubMed ID: 30585591
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Cytoflavin® effect on endothelium function and cerebral hemodynamics in patients with hypertensive enceplalopathy].
    Belova LA; Mashin VV; Kolotik-Kameneva OY; Proshin AN
    Antibiot Khimioter; 2014; 59(7-8):30-6. PubMed ID: 25975105
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Experience of cytoflavin administration for treating acute carbon monoxide poisoning].
    Zobnin IuV; Petrova AG; Provado IP; Afanas'ev VV
    Eksp Klin Farmakol; 2011; 74(10):39-42. PubMed ID: 22238986
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Cytoflavin rationale for the use in treatment of patients with postsurgical hypothyroidism].
    Skripkо VD; Pasko AJ; Kovalenko AL; Zaplutanov VA
    Khirurgiia (Mosk); 2016; (7):53-57. PubMed ID: 27459489
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Assessment of multimodal effect of cytoflavin in the acute brain stroke in patients with metabolic syndrome].
    Asadullaev MM; Saidvaliev FS; Shermukhamedova FK; Rizvonov ZhK; Vakhabova NM
    Zh Nevrol Psikhiatr Im S S Korsakova; 2012; 112(10):24-7. PubMed ID: 23250593
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Cytoflavin in total intravenous anesthesia].
    Ovezov AM; Bragina SV; Prokoshev PV
    Vestn Khir Im I I Grek; 2010; 169(2):64-7. PubMed ID: 20552794
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Efficiency of intensive care with cytoflavin in patients of advanced age in combined traumatic brain injury].
    Lebedeva EA; Belousova ME; Kurtasov AA; Nemkova ZA; Kaminskiĭ MIu; Popov RV; Trofimovich SL
    Adv Gerontol; 2014; 27(3):578-83. PubMed ID: 25827011
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [STRESS-PROTECTIVE EFFECT OF CYTOFLAVIN ON CHRONIC CEREBRAL ISCHEMIA IN RATS.].
    Krylov VN; Deryugina AV; Antipenko EA
    Eksp Klin Farmakol; 2016; 79(9):29-32. PubMed ID: 29787669
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Cardioprotective effect of cytoflavine on a model of doxorubicin-induced cardiomyopathy].
    Kashuro VA; Glushkov SI; Novikova TM; Aksenov VV
    Eksp Klin Farmakol; 2010 Mar; 73(3):15-7. PubMed ID: 20408423
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Behavioral psychotherapy and citoftavin in the treatment of deforming coxarthrosis in elderly patients].
    Zakharov KI; Parfyenov SA; Belov VG; Parfyenov UA; Ershov EV; Sapozhnikov KV; Kovalenko AL; Haritonova TV; Skripko VD
    Adv Gerontol; 2016; 29(5):816-821. PubMed ID: 28556655
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Using cytoflavin for prophylaxis and treatment of cognitive amnestic disorders in patients with heavy toxicohypoxic damage of brain].
    Batotsyrenova KhV; Livanov GA; Shestova GV; Sizova KV; Velikova VD
    Eksp Klin Farmakol; 2012; 75(9):28-31. PubMed ID: 23156085
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Substantiation of the drug «Cytoflavin» application and cognitive-behavioral therapy in complex treatment of deforming coxarthrosis in elderly patients.].
    Zakharov IK; Belov VG; Parfyonov UA; Parfyonov SA; Ershov EV; Sapozhnikov KV; Zaplutanov VA
    Adv Gerontol; 2019; 32(3):439-444. PubMed ID: 31512432
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Antioxidant activity of cytoflavin in experimental diffuse purulent peritonitis].
    Kosinets VA
    Eksp Klin Farmakol; 2010 Jan; 73(1):30-2. PubMed ID: 20184286
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Efficacy of the energy-modifier cytoflavin in the treatment of patients with hypertensive encephalopathy].
    Belova LA; Kolotik-Kameneva OIu; Mashin VV; Saprygina LV; Mashin EV
    Ter Arkh; 2014; 86(9):65-70. PubMed ID: 25518508
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The influence of cytoflavin and cardioxipin on the indices of lipid peroxidation and antioxidant protection in the blood of rat with dyslipidemia].
    Vodop'ianova OA; Moiseeva IIa; Rodina OP; Kustikova IN; Antropova NV
    Eksp Klin Farmakol; 2014; 77(6):27-9. PubMed ID: 25102732
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Use of cytoflavin into the complex intensive therapy of acute cerebral insufficiency caused by poisoning].
    Vasilyev S; Shilov V; Aleksandrov M; Batotsyrenov B; Loladze A
    Georgian Med News; 2012 Feb; (203):22-9. PubMed ID: 22466536
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Pathogenetic therapy of tuberculosis of respiratory organs during sanatorium-and-spa treatment].
    Sukhanov DS; Ivanov AK; Kovalenko AL; Dziuba EG; Andreeva MN; Romantsov MG
    Vopr Kurortol Fizioter Lech Fiz Kult; 2009; (6):34-7. PubMed ID: 20017380
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.